Donor‐transmitted malaria after heart transplant managed successfully with artesunate

Donor‐transmitted malaria is a rare complication in solid organ transplantation, which causes high mortality. Data concerning the use of artesunate in solid organ transplant recipients are lacking. We report a heart transplant patient who developed donor‐derived severe Plasmodium falciparum malaria,...

Full description

Saved in:
Bibliographic Details
Published in:Transplant infectious disease 2014-12, Vol.16 (6), p.999-1002
Main Authors: Sabé, N., González‐Costello, J., Oriol, I., Sánchez‐Salado, J.C., Ortega, S., Oliver, E., Manito, N., Carratalà, J.
Format: Article
Language:English
Subjects:
Antimalarials - therapeutic use
Artemisinins - therapeutic use
artesunate
erythropheresis
heart transplant
Heart Transplantation - adverse effects
Humans
Malaria
Malaria, Falciparum - drug therapy
Malaria, Falciparum - transmission
Male
Middle Aged
Plasmodium falciparum - isolation & purification
severe malaria
solid organ transplantation
Tissue Donors
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Donor‐transmitted malaria is a rare complication in solid organ transplantation, which causes high mortality. Data concerning the use of artesunate in solid organ transplant recipients are lacking. We report a heart transplant patient who developed donor‐derived severe Plasmodium falciparum malaria, successfully treated with artesunate. Transmission of malaria to 2 of the other transplant recipients from the same donor was also documented.
ISSN:1398-2273
1399-3062
DOI:10.1111/tid.12299